[Juvenile idiopathic arthritis. II. Treatment and prognosis]. / Arthrites juvéniles idiopathiques. II. Traitement et pronostic.

Immunosuppressants, including methotrexate and more recently anti-TNFalpha, have modified the prognosis of the most severe forms juvenile idiopathic arthritis. However, the therapeutic management is still challenging and adjuvant therapies, including physiotherapy, surgery, or even bisphosphonates and growth hormone, are still widely used to limit the negative impact of an extended general corticotherapy.